Key Points

  • Fetal tumours are rare and should be managed by an experienced multidisciplinary team.

  • Magnetic resonance imaging is an important imaging modality in the diagnosis and management of fetal tumours.

  • Fetal neck masses may result in airway obstruction and the ex utero intrapartum treatment (EXIT) procedure may need to be planned for delivery.

  • In utero treatment of sacrococcygeal teratomas can be performed in fetuses showing signs of compromise.

  • Good outcomes can be achieved in many cases of fetal tumours.

Introduction

Fetal tumours are a rare and heterogeneous group of fetal malformations, ranging from benign lesions that may cause fatal airway obstruction without appropriate management, through those with mass effect and low malignant potential, to very rare fetal malignancies. The unifying feature is that they are rare and require complex antenatal, intrapartum and postnatal management from highly specialist services. With improvements in antenatal detection and assessment, involvement of the multidisciplinary team (MDT) and individualised care planning and management from the point of diagnosis, devastating and fatal outcomes such as unexpected airway obstruction or massive fetal or neonatal haemorrhage can be avoided, and potentially, the outcomes for these infants can be improved.

Neck Masses

Introduction

Neck masses are most commonly noted in the second trimester at the time of the detailed anatomy scan, although they may present as an incidental finding on later scans or be referred due to polyhydramnios and measuring large for gestational age. The majority of neck masses detected at this gestational age are mixed cystic and solid in nature and arise in the anterior triangle. Posterior cystic neck lesions and those evident in the first trimester commonly have a different aetiology as outlined later and in Chapter 19 .

The two most common neck masses are lymphangiomas and teratomas. A lymphangioma will be a well-circumscribed, predominantly avascular mass consisting of thin walled cystic areas. Lymphangiomas arise laterally but often crosses the midline, and although not invasive, they can extend into the mediastinum and thoracic cavity and can obstruct the airway ( Fig. 37.1 ).

• Fig. 37.1, A, Ultrasound image of a lymphangioma at 25 weeks’ gestation. Note the thin-walled cystic nature of the lesion. B, Ultrasound images of a teratoma at 23 weeks’ gestation measuring 61.8 × 41.8 mm. Note the mixed solid and cystic component and massive size.

A teratoma has a heterogeneous appearance with varying degrees of cystic and solid components ( Fig. 37.2 ). They are often well vascularised. There is no pathognomonic ultrasound appearance, and teratomas can be difficult to differentiate from lymphangiomas. However, areas of calcification on ultrasound (or fat signal on magnetic resonance imaging (MRI)) make the diagnosis of teratoma more likely. As with lymphangiomas, fetal teratomas are rarely invasive but can cause oropharyngeal obstruction and deviation. Compressive effects can also cause significant disruption to the bony skull and the skull base; ultrasound (US) and MRI should be used to detect signs of this. Care should be taken to differentiate a cervical teratoma from an epignathus, a rare teratoma arising from the palate-pharyngeal region around the basisphenoid (Rathke pouch), which fills the buccal cavity. This is associated with poor prognosis because of the location and potential for invasion into the skull base and brain tissue.

• Fig. 37.2, A and B, Teratoma at 20 weeks’ gestational age, demonstrating the relationship with the nose, mouth, neck and thorax. The mass measures 37.6 × 37mm. C, Teratoma at 32 weeks’ gestational age. Doppler can be used to help identify the airway. Movement of fluid is suggestive, although not diagnostic, of airway patency. D, Vascular teratomas. Doppler can be used to assess the vascularity of the lesion and the blood flow within it.

Differential Diagnoses

Before confirmation of a cystic neck mass, other differentials must be considered. Posteriorly, this would primarily be gross nuchal oedema. Careful US examination of the skull and brain structure should be performed to exclude encephalocele or cervical myelomeningocele. Anteriorly, cervical teratoma is a primary differential. Anomalies of thyroid development, including tumours and goitres can present similarly. Masses with a more cystic appearance may represent thyroid or branchial cleft cysts or thyroglossal duct cysts.

Cystic Lymphangioma

Embryologically, the lymphatic system develops after the formation of blood vessels. The most widely accepted model of lymphatic development to date was developed more than a century ago. It proposes that the endothelial cells bud from the veins to form primary lymphatic sacs. These then sprout towards the periphery. The two main lymphatic sacs develop near the junction of the subclavian and anterior cardinal veins, and the lymphatic capillaries spread from these towards the head, neck, arm and thorax. The failure of these jugular lymph sacs to drain into the developing lymphatic system is thought to cause abnormal lymphatic sprouting, lymph accumulation and the development of lymphangiomas.

The terms cystic hygroma and lymphangioma are synonymous and have been used to describe congenital dilated cystic malformations, predominantly in the region of the neck. However, it should be recognised that these masses may arise from or extend into the thorax and mediastinum or axilla. Less commonly, lymphangiomas have been reported elsewhere in fetuses, including the extremities and abdominal wall.

In the first trimester, the term cystic hygroma is used to describe a significantly increased nuchal translucency, often with internal septations (see Chapter 19 ). Such cases are more frequently associated with underlying chromosomal aneuploidies, particularly monosomy X (Turner syndrome), trisomy 18 and trisomy 21. In the absence of aneuploidy, there is a higher incidence of underlying genetic disorders that may not be detected antenatally. However, in the era of microarray and improved targeted testing for Noonan syndrome (in which >80% can be diagnosed), the antenatal detection rate is improving. A detailed first trimester anomaly scan, including cardiac anatomy, should be performed in such cases and further investigations offered. In the event of a normal karyotype or microarray, if the findings do not resolve, and particularly if there is a further anomaly found on ultrasound, genetic counselling should be considered. If antenatal testing is declined, careful assessment of the infant should be performed in the neonatal period.

Increased nuchal translucency is also associated with cardiac abnormalities, and in some cases, ultrasound signs of fluid in other fetal compartments such as the thorax, abdomen and generalised skin oedema may be noted; this is known as fetal hydrops or hydrops fetalis. In cases of hydrops, investigations as described earlier should be performed, as well as consideration of other causes such as red cell alloimmunisation or nonimmune causes, including viral infection and metabolic disease (see Chapter 36 ). In cases of persistent hydrops presenting in the first trimester, the outlook is very poor with few fetuses surviving to delivery.

In cases of first trimester cystic hygromas that have been appropriately investigated and no genetic abnormality found, particularly in those cases that resolve, the prognosis is very good.

The development of a cystic neck mass in the second trimester is likely to have a different aetiology ( Table 37.1 ) from those seen in the first trimester and may carry a better prognosis unless associated with hydrops or generalised oedema, in which cases the prognosis remains poor.

TABLE 37.1
Table of Differential Diagnosis of Fetal Neck Masses
Diagnosis Ultrasound features Incidence Outcome
Cervical lymphangiomas Well-circumscribed or diffuse cystic mass, laterally located, and often arising from cervical area, floor of mouth or the tongue 1 in 1775 live births Can cause complex airway obstruction; referral to ENT and consideration of EXIT procedure recommended; presence in the first trimester is associated with chromosomal abnormalities
Cervical teratomas Can be massive, usually solid with some cystic areas, and well defined; may have internal calcifications, positioned in the anterior neck; 3:1 female:male ratio 1 in 40,000 live births Can cause complex airway obstruction; referral to ENT and consideration of EXIT procedure are recommended
Haemangioma Typically posterolateral, well-defined, solid masses with slow vascular flow Rare May be associated with cortical malformations; brain MRI indicated, can be part of PHACES syndrome
Cervical thymic cyst Commonly multiloculated but can be uniloculated, most commonly to the left, splaying the carotid artery and jugular vein Very rare
Congenital goitre Symmetric thyroid enlargement; associated with maternal propylthiouracil use (for Graves’ disease) and maternal thyroid stimulation-blocking antibody Rare Unlikely to cause airway obstruction; when present, intubation is usually successful
Brachial cleft cysts Unilateral, uniloculated anterolateral thin-walled cyst Rare Not reported to cause airway obstruction
Vascular malformations Multiloculated cystic structure often laterally located Rare
Neuroblastoma Retropharyngeal, solid mass, with or without calcification, extending into mediastinum or skull Very rare
ENT, Ear, nose and throat; EXIT, ex utero intrapartum treatment; MRI, magnetic resonance imaging; PHACES, posterior fossa malformation, haemangiomas, arterial anomalies, cardiac defects, eye abnormalities and sternal cleft.

Teratomas

Fetal teratomas are rare tumours with an incidence of 1 in 40,000 live births. Although most commonly found in the region of the lower spine and pelvis (sacrococcygeal teratomas (SCTs); discussed in detail later), 6% are related to the neck. Teratomas are (almost always) formed of tissues derived from the three germ cell layers: endoderm, mesoderm and ectoderm. Although teratomas are predominantly (>80%) benign tumours with well-differentiated tissues, the rapid growth and the mass effect can cause significant complications; primarily by obstruction or deviation of the trachea and oesophagus. In cases of immature teratoma, with more poorly differentiated tissues, there in increased risk for invasion and metastases; however, the prognosis remains good with a greater than 80% 5-year survival rate.

The origin of fetal teratomas remains poorly understood. The most widely accepted hypothesis is that aberrant pluripotent cells are sequestered during embryogenesis, in the fourth to fifth week of gestation, that are able to proliferate to form disorganised structures comprising tissue types derived from the three embryonic germ layers.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here